V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20023248 | 20009868 | 1.66 | 77.1 | Adjuvant (A) | 2017-07-21 | 2017-07-27 | FEC 100 + DOCETAXEL | 1 | null | 20082080 | FEC + DOCETAXEL |
| 20023249 | 20009869 | 1.6 | 79 | Adjuvant (A) | 2013-10-23 | 2013-11-11 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20082086 | FEC + DOCETAXEL |
| 20023250 | 20009869 | 1.64 | null | Adjuvant (A) | 2013-05-29 | 2013-06-07 | FEC + DOCETAXEL | N | N | 20082086 | FEC + DOCETAXEL |
| 20023251 | 20009869 | 1.54 | 73 | Adjuvant (A) | 2017-02-15 | 2017-03-01 | FEC 100 + DOCETAXEL | N | Y | 20082086 | FEC + DOCETAXEL |
| 20023252 | 20009870 | 1.54 | 52 | Adjuvant (A) | 2015-03-19 | 2015-04-05 | FEC 100 + DOCETAXEL | 2 | N | 20082110 | FEC + DOCETAXEL |
| 20023253 | 20009871 | 1.65 | 72 | Adjuvant (A) | 2017-06-18 | 2017-07-12 | FEC 100 + DOCETAXEL | N | N | 20082114 | FEC + DOCETAXEL |
| 20023254 | 20009871 | null | 63.6 | Adjuvant (A) | 2014-08-22 | 2014-09-12 | FEC 100 + DOCETAXEL | N | null | 20082114 | FEC + DOCETAXEL |
| 20023255 | 20009871 | 1.58 | 82 | Adjuvant (A) | 2014-06-13 | 2014-06-29 | FEC + DOCETAXEL | 99 | N | 20082114 | FEC + DOCETAXEL |
| 20023256 | 20009872 | 1.58 | 86.2 | Curative (C) | 2017-08-08 | 2017-08-15 | FEC + DOCETAXEL | 02 | N | 20082127 | FEC + DOCETAXEL |
| 20023257 | 20009873 | 1.67 | 60 | Neo-adjuvant (N) | 2016-11-08 | 2016-11-09 | FEC + DOCETAXEL | 02 | N | 20082128 | FEC + DOCETAXEL |
| 20023258 | 20009873 | 1.65 | 71 | Adjuvant (A) | 2016-09-28 | 2016-10-25 | FEC + DOCETAXEL | null | null | 20082128 | FEC + DOCETAXEL |
| 20023259 | 20009874 | 172 | 59.9 | Adjuvant (A) | 2015-12-13 | 2015-12-28 | FEC + DOCETAXEL | N | N | 20082142 | FEC + DOCETAXEL |
| 20023260 | 20009874 | 1.73 | 68.8 | Adjuvant (A) | 2014-04-08 | 2014-05-04 | FEC 100 + DOCETAXEL | N | N | 20082142 | FEC + DOCETAXEL |
| 20023261 | 20009874 | null | null | Adjuvant (A) | null | 2016-02-08 | FEC 100 + DOCETAXEL | null | null | 20082142 | FEC + DOCETAXEL |
| 20023262 | 20009875 | 1.6 | 71.9 | null | 2013-06-23 | 2013-07-22 | FEC + DOCETAXEL | N | N | 20082153 | FEC + DOCETAXEL |
| 20023263 | 20009876 | 1.73 | 60 | Neo-adjuvant (N) | 2016-09-09 | 2016-09-16 | FEC 100 + DOCETAXEL | 02 | Y | 20082161 | FEC + DOCETAXEL |
| 20023264 | 20009877 | 1.74 | 65.3 | Adjuvant (A) | 2018-02-01 | 2018-02-02 | FEC + DOCETAXEL | N | null | 20082162 | FEC + DOCETAXEL |
| 20023265 | 20070666 | null | null | Neo-adjuvant (N) | 2014-03-28 | 2014-04-19 | FEC + DOCETAXEL | 99 | N | 20082168 | FEC + DOCETAXEL |
| 20023266 | 20070666 | 1.74 | 84 | Adjuvant (A) | 2015-08-04 | 2015-08-08 | FEC + DOCETAXEL | N | N | 20082168 | FEC + DOCETAXEL |
| 20023267 | 20009878 | 1.6 | 97.75 | Adjuvant (A) | 2015-04-20 | 2015-04-20 | FEC 100 + DOCETAXEL | 2 | N | 20082187 | FEC + DOCETAXEL |
| 20023268 | 20009878 | 1.72 | 80 | Adjuvant (A) | 2017-10-13 | 2017-11-02 | FEC + DOCETAXEL | 2 | N | 20082187 | FEC + DOCETAXEL |
| 20023269 | 20009878 | null | null | Adjuvant (A) | 2016-02-23 | 2016-03-25 | FEC 100 + DOCETAXEL | N | N | 20082187 | FEC + DOCETAXEL |
| 20023270 | 20009878 | 1.65 | 66 | Adjuvant (A) | null | 2013-10-31 | FEC 100 + DOCETAXEL | null | N | 20082187 | FEC + DOCETAXEL |
| 20023271 | 20009879 | 1.66 | 57.4 | Curative (C) | 2014-05-08 | 2014-05-08 | FEC + DOCETAXEL | 02 | null | 20082200 | FEC + DOCETAXEL |
| 20023272 | 20009880 | 1.59 | 62 | Curative (C) | 2017-10-05 | 2017-10-05 | FEC 100 + DOCETAXEL | 02 | N | 20082203 | FEC + DOCETAXEL |
| 20023273 | 20009881 | 1.74 | 71 | Adjuvant (A) | 2016-02-04 | 2016-02-23 | FEC + DOCETAXEL | N | N | 20082210 | FEC + DOCETAXEL |
| 20023274 | 20009882 | 1.61 | 84.1 | Adjuvant (A) | 2016-02-02 | 2016-02-05 | FEC + DOCETAXEL | 2 | N | 20082212 | FEC + DOCETAXEL |
| 20023275 | 20009882 | 1.68 | 76.2 | Curative (C) | 2014-07-14 | 2014-07-15 | FEC 100 + DOCETAXEL | 02 | N | 20082212 | FEC + DOCETAXEL |
| 20023276 | 20009882 | 1.63 | 86 | Adjuvant (A) | 2015-11-19 | 2015-11-25 | FEC + DOCETAXEL | 02 | N | 20082212 | FEC + DOCETAXEL |
| 20023277 | 20009882 | null | null | Neo-adjuvant (N) | 2015-05-14 | 2015-05-15 | FEC 100 + DOCETAXEL | null | N | 20082212 | FEC + DOCETAXEL |
| 20023278 | 20009882 | 1.69 | 74 | Adjuvant (A) | 2015-11-06 | 2015-12-16 | FEC + DOCETAXEL | 2 | N | 20082212 | FEC + DOCETAXEL |
| 20023279 | 20009883 | null | 83 | Adjuvant (A) | 2013-08-03 | 2013-08-18 | FEC + DOCETAXEL | N | N | 20082248 | FEC + DOCETAXEL |
| 20023280 | 20009883 | 1.66 | 86.9 | Curative (C) | 2017-08-29 | 2017-09-06 | FEC + DOCETAXEL | 2 | N | 20082248 | FEC + DOCETAXEL |
| 20023281 | 20009883 | 1.61 | 59.9 | Adjuvant (A) | 2018-01-10 | 2018-01-10 | FEC + DOCETAXEL | 2 | N | 20082248 | FEC + DOCETAXEL |
| 20023282 | 20009883 | 1.63 | 109 | Adjuvant (A) | 2016-06-26 | 2016-06-26 | FEC + DOCETAXEL | 02 | N | 20082248 | FEC + DOCETAXEL |
| 20023283 | 20009884 | 1.61 | 81 | Curative (C) | 2013-09-16 | 2013-09-24 | FEC + DOCETAXEL | 2 | N | 20082258 | FEC + DOCETAXEL |
| 20023284 | 20009885 | null | null | Neo-adjuvant (N) | 2015-12-10 | 2015-12-11 | FEC + DOCETAXEL | N | N | 20082262 | FEC + DOCETAXEL |
| 20023285 | 20009885 | 1.55 | 80 | null | 2017-08-31 | 2017-09-07 | FEC + DOCETAXEL | N | N | 20082262 | FEC + DOCETAXEL |
| 20023286 | 20009885 | 1.62 | 78.3 | Neo-adjuvant (N) | 2014-05-15 | 2014-05-29 | FEC + DOCETAXEL | N | N | 20082262 | FEC + DOCETAXEL |
| 20023287 | 20009886 | 1.65 | 80.6 | Neo-adjuvant (N) | 2016-06-23 | 2016-06-23 | FEC + DOCETAXEL | 02 | N | 20082266 | FEC + DOCETAXEL |
| 20023288 | 20009886 | null | 85.2 | null | 2016-06-14 | 2016-07-11 | FEC + DOCETAXEL | 2 | N | 20082266 | FEC + DOCETAXEL |
| 20023289 | 20009886 | 1.55 | 86.9 | Not known (9) | 2017-08-29 | 2017-08-29 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20082266 | FEC + DOCETAXEL |
| 20023290 | 20009886 | 1.66 | 75.8 | Curative (C) | 2013-09-09 | 2013-09-24 | FEC 100 + DOCETAXEL | 02 | N | 20082266 | FEC + DOCETAXEL |
| 20023291 | 20009887 | 1.66 | 72.4 | Neo-adjuvant (N) | 2015-02-02 | 2015-02-13 | FEC + DOCETAXEL | 02 | N | 20082286 | FEC + DOCETAXEL |
| 20023292 | 20009887 | 1.57 | 54.25 | null | 2014-02-28 | 2014-03-23 | FEC 100 + DOCETAXEL | N | null | 20082286 | FEC + DOCETAXEL |
| 20023293 | 20009887 | 1.74 | 72.65 | Adjuvant (A) | 2015-08-18 | 2015-08-27 | FEC 60 OR 75 + DOCETAXEL | 2 | Y | 20082286 | FEC + DOCETAXEL |
| 20023294 | 20009887 | null | 76.6 | Curative (C) | 2014-03-30 | 2014-05-01 | FEC + DOCETAXEL | N | N | 20082286 | FEC + DOCETAXEL |
| 20023295 | 20009887 | null | null | Neo-adjuvant (N) | 2014-01-26 | 2014-01-26 | FEC + DOCETAXEL | null | null | 20082286 | FEC + DOCETAXEL |
| 20023296 | 20009888 | 1.75 | 89.7 | Adjuvant (A) | 2017-02-11 | 2017-02-17 | FEC + DOCETAXEL | 02 | N | 20082304 | FEC + DOCETAXEL |
| 20023297 | 20009889 | 1.58 | 72.2 | Neo-adjuvant (N) | 2014-04-06 | 2014-04-06 | FEC 100 + DOCETAXEL | 02 | N | 20082306 | FEC + DOCETAXEL |